| 000 | 00640naa a2200217 i 4500 | ||
|---|---|---|---|
| 001 | 15806 | ||
| 003 | ES-MaBCM | ||
| 005 | 20241016092008.0 | ||
| 008 | 910917s1991 gbr 000 0 eng d | ||
| 021 | _axx | ||
| 035 | _a(OCoLC)1365137047 | ||
| 040 | _cES-MaBCM | ||
| 041 | 0 | _aeng | |
| 043 | _agbr | ||
| 100 | 1 |
_aGeddes, Andrew _918368 |
|
| 245 | 1 | 0 |
_aFree movement of fharmaceuticals within the community _b: the remaining barriers _cAndrew Geddes |
| 650 | 7 |
_aFarmacéutico _958687 |
|
| 650 | 2 | 4 |
_aComunidad Europea _951001 |
| 773 | 0 |
_aEn: _tEuropean law review _dBirmingham : 1991 _w104621 _gnº 4, agosto ; p. 295-306 |
|
| 942 | _cAREV | ||
| 999 |
_c15806 _d15806 |
||